Control disease activity and correct iron deficit when iron-deficiency anaemia occurs in patients with inflammatory bowel disease

摘要

Anaemia, most commonly iron-deficiency anaemia, is a frequent extra-intestinal complication of inflammatory bowel disease (IBD). When treating iron-deficiency anaemia, IBD activity should be controlled and the iron deficit corrected. The preferred route of iron supplementation is generally intravenous, but oral administration may be an option in some patients. Only a limited number of patients require treatment with erythropoietin or blood transfusions. Anaemia represents one of the most frequent systemic manifestations of inflammatory bowel disease (IBD) [1, 2]. It affects health-related quality of life and the ability to work, and can also lead to an increase in complications or even death [1,2].